Abstract:Loss-of-function mutations in the PTEN-induced kinase 1 (PINK1) or parkin genes, which encode a mitochondrially localized serine/threonine kinase and a ubiquitin-protein ligase, respectively, result in recessive familial forms of Parkinsonism. Genetic studies in Drosophila indicate that PINK1 acts upstream of Parkin in a common pathway that influences mitochondrial integrity in a subset of tissues, including flight muscle and dopaminergic neurons. The mechanism by which PINK1 and Parkin influence mitochondrial integrity is currently unknown, although mutations in the PINK1 and parkin genes result in enlarged or swollen mitochondria, suggesting a possible regulatory role for the PINK1/Parkin pathway in mitochondrial morphology. To address this hypothesis, we examined the influence of genetic alterations affecting the machinery that governs mitochondrial morphology on the PINK1 and parkin mutant phenotypes. We report that heterozygous loss-of-function mutations of drp1, which encodes a key mitochondrial fission-promoting component, are largely lethal in a PINK1 or parkin mutant background. Conversely, the flight muscle degeneration and mitochondrial morphological alterations that result from mutations in PINK1 and parkin are strongly suppressed by increased drp1 gene dosage and by heterozygous loss-of-function mutations affecting the mitochondrial fusion-promoting factors OPA1 and Mfn2. Finally, we find that an eye phenotype associated with increased PINK1/Parkin pathway activity is suppressed by perturbations that reduce mitochondrial fission and enhanced by perturbations that reduce mitochondrial fusion. Our studies suggest that the PINK1/Parkin pathway promotes mitochondrial fission and that the loss of mitochondrial and tissue integrity in PINK1 and parkin mutants derives from reduced mitochondrial fission.

PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's disease

Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond

The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria

The role of PINK1–Parkin in mitochondrial quality control

Pink1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy

The Pink-Parkin Circuit in Mitochondrial Quality Control

PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?

Parkin, an E3 Ubiquitin Ligase, Plays an Essential Role in Mitochondrial Quality Control in Parkinson’s Disease

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease

PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease

Building and decoding ubiquitin chains for mitophagy

PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin

Parkin Is Dispensable for Mitochondrial Function, but Its Ubiquitin Ligase Activity Is Critical for Macroautophagy and Neurotransmitters: Therapeutic Potential beyond Parkinson's Disease

PINK1-mediated phosphorylation of Parkin boosts Parkin activity in Drosophila

PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models

The PINK1/Parkin pathway regulates mitochondrial morphology

Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation

Analysis of Neuronal Phosphoproteome Reveals PINK1 Regulation of BAD Function and Cell Death.

PINK1/Parkin Mediated Mitophagy, Ca2+ Signalling, and ER–Mitochondria Contacts in Parkinson’s Disease

Inhibition of Mir-421 Preserves Mitochondrial Function and Protects Against Parkinson’s Disease Pathogenesis Via Pink1/Parkin-Dependent Mitophagy